Our findings highlight a hitherto-unknown mechanism by which LOXL2 and L2Δ13 catalyze the deacetylation of aldolase to stimulate its mobilization and enzymatic activity in glycolysis that in turn promotes tumor progression. Here, LOXL2 is linked to neoplasm.